National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1316494

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/9/2021

VAERS ID: 1316494
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: C-reactive protein, Dyspnoea, Fall, Oxygen saturation decreased, White blood cell count, Red blood cell sedimentation rate, General physical health deterioration, Pelvic fracture, Procalcitonin, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: Test Name: CRP; Result Unstructured Data: Test Result:50; Test Name: PCT; Test Result: Negative ; Test Name: sedimentation rate; Result Unstructured Data: Test Result:25; Test Name: PCR COVID; Test Result: Negative ; Test Name: leuco; Result Unstructured Data: Test Result:16000
CDC 'Split Type': FRPFIZER INC2021521546

Write-up: fell, resulting in a fractured pelvis; fell, resulting in a fractured pelvis; dyspnea; desaturation; Reduced general condition; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) -WEB, regulatory authority number FR-AFSSAPS-DJ20211036. A 90-year-old female patient received bnt162b2 (Pfizer vaccine), intramuscular on 12Apr2021 (Batch/Lot Number: EW2246) as 2ND DOSE, SINGLE for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 15Apr2021, the patient experienced reduced general condition. It was further reported that on 15Apr2021, 4 days after vaccination, there was a deterioration in general condition, dyspnea and desaturation requiring oxygen therapy. Biological inflammatory syndrome: leuco: 16000, C-reactive protein (CRP): 50, sedimentation rate: 25, procalcitonin (PCT) was negative, and polymerase chain reaction (PCR) COVID was negative. Additionally, it was reported that 2 days after the onset of symptoms (17Apr2021), the patient fell, resulting in a fractured pelvis. It was decided in agreement with the family to keep the patient at home and not to persevere. Continuation of comfort care with oxygen (O2), medical bed at home with family warned of the rapid rate of degradation. On 25Apr2021, 14 days after the vaccination, the patient died. The patient had no COVID-19 disease history. In total, there was a deterioration in general condition 4 days after the injection of a second dose of bnt162b2 vaccine. Therapeutic measures were taken as a result of dyspnea and desaturation. The outcome of fell, resulting in a fractured pelvis, and dyspnea and desaturation requiring oxygen therapy was unknown while event reduced general condition resulted to fatal outcome. The patient died on 25Apr2021. An autopsy was not performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: reduced general condition

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166